Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE studyOliver A. Cornely, Sílvia Gómez-Zorrilla, José Miguel Cisneros et al.|Journal of Antimicrobial Chemotherapy|2019Cited by 123
Factors associated with recruitment success in the phase 2a study of aztreonam–avibactam development programme: a descriptive qualitative analysis among sites in SpainRosa M. Jiménez-Rodríguez, José Miguel Cisneros, Ángela Cano et al.|BMJ Open|2022Cited by 2